The Pirbright Institute, through the Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM), has entered into a new agreement with GALVmed to develop and deploy a safer and more effective […]
On Friday, 1st August 2025, Prof. Barnabas Nawangwe, Vice Chancellor of Makerere University, officially inaugurated the newly upgraded Research Centre for Tropical Diseases and Vector Control (RTC) Lab at the College of […]
(18 June 2025, Edinburgh, UK) – The Board of GALVmed is pleased to announce the appointment of Dr. Lois Muraguri as the new Chief Executive Officer of GALVmed. Dr. Muraguri […]
The new programme will aim to improve ruminant vaccination rates in Kenya, Tanzania and Nigeria over a five year period. EDINBURGH, UK, March 28, 2025 – The Global Alliance for […]
Whilst the burden of human sleeping sickness has been reduced by more than 95%, Nagana – caused by different species of trypanosomes- continues to undermine livestock productivity across vast swathes […]
We’re excited to share GALVmed’s 2024 Year in Review. From product and market development to strategic partnerships and regulatory progress, this comprehensive report highlights the milestones and achievements that shaped […]
At GALVmed, we know that small-scale livestock producers can, with the necessary support and access to animal health solutions, become engines of financial growth and social transformation in the Global […]
GALVmed is excited to announce the search for a new Chief Executive Officer as current CEO, Carolin Schumacher, prepares to step down later this year after providing exceptional leadership and […]
The control of Foot and Mouth Disease (FMD) in the Eastern Africa Region is now a step closer thanks to a newly registered first ever quadrivalent FMD vaccine tailored for […]
Photo: ILRI/K.Dhanji Edinburgh, UK (27th August 2024) – Veterinary pharmaceutical companies can now register veterinary ectoparasiticides (pesticides) within the East African Community (EAC) under the Mutual Recognition Procedure (MRP). This […]
